Topiramate Tablet, Film Coated
Product Images NDC 71205-214

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71205-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-214-60 (25mg)

This is a description of a medication called Topiramate 25mg distributed by Proficent Rx LP. The package includes #90 circular film-coated tablets, and each tablet contains 25mg of topiramate, USP. It is important to dispense the medication with a medication guide to the patients, and store it at 20°-25°C (68°-77°F). The product ID is QT021490 and the lot number is 00000. The medication should be kept out of reach of children.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-1jpg (Figure 1)

This is a figure illustrating the Kaplan-Meier estimates of cumulative rates for time to the first seizure. The figure compares the rates of topiramate 50 mg/day (N= 234) and topiramate 400 mg/day (N=236) treatments. The x-axis represents time in days, while the y-axis represents cumulative rates. The plot shows that the topiramate 400 mg/day treatment had a lower cumulative rate of seizures compared to the topiramate 50 mg/day treatment. The p-value for this difference was calculated as 0.0002.*

FDA Label Image

Figure-2 (Figure 2)

The text provides a chart that shows the average monthly rate of migraine periods for different doses of topiramate and a placebo, from baseline to double-blind phase. The chart includes results from studies 10 and 11, and shows statistical significance with p-values.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.